new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Crucell Holland B v
Crucell Holland B v_20100121
  

Crucell Holland B v patents

Recent patent applications related to Crucell Holland B v. Crucell Holland B v is listed as an Agent/Assignee. Note: Crucell Holland B v may have other listings under different names/spellings. We're not affiliated with Crucell Holland B v, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Crucell Holland B v-related inventors




Date Crucell Holland B v patents (updated weekly) - BOOKMARK this page
03/30/17Cold-adapted-viral-attenuation (cava) and novel attenuated poliovirus strains
11/03/16Formulations for virosomes
11/03/16Formulations for virosomes
10/20/16Process for preparing influenza vaccines
08/04/16Method for the clarification of high density crude cell culture harvest
07/14/16Improved adenovirus formulations
07/14/16Method for preparing virosomes
07/07/16Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
06/23/16Stabilized soluble pre-fusion rsv f polypeptides
06/02/16Method for preparing virosomes
05/26/16Human antibodies binding to rsv g protein
05/26/16Human antibodies binding to rsv g proteins
05/19/16Influenza virus vaccines and uses thereof
05/12/16Method for preparing virosomes
05/05/16Therapeutic hpv16 vaccines
04/14/16Stabilized soluble prefusion rsv f polypeptides
03/31/16Methods and compositions for inducing protective immunity against human immunodeficiency virus infection
01/28/16Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
01/07/16Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
11/12/15Vaccine against rsv
10/01/15Human binding molecules able to neutralize influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
09/03/15Replicating recombinant adenovirus vectors, compositions, and methods of use thereof
08/20/15Human binding molecules capable of binding to and neutralizing hepatitis b viruses and uses thereof
07/23/15Adenoviral vectors for transduction of vascular tissue
07/16/15Vaccine against rsv
06/25/15Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
03/26/15Acellular pertussis vaccine
02/05/15Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
01/08/15Complementing cell lines
09/11/14Acellular pertussis vaccine
08/28/14Production of poliovirus at high titers for vaccine production
07/03/14Vaccine against rsv
05/29/14Vaccine against rsv
05/01/14Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
04/10/14Human binding molecules having killing activity against enterococci
03/13/14Batches of recombinant adenovirus with altered terminal ends
03/06/14Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
03/06/14Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
02/13/14Antibodies against human respiratory syncytial virus (rsv) and methods of use
01/16/14Adenovirus serotype 26 and serotype 35 filovirus vaccines
09/19/13Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
09/19/13Humanized anti-cxcr5 antibodies, derivatives thereof and their use
09/12/13Vaccination against influenza
07/04/13Therapeutic vaccination against active tuberculosis
05/16/13Heterologous prime-boost immunization using measles virus-based vaccines
02/28/13Production of poliovirus at high titers for vaccine production
08/09/12Process for adenovirus purification from high cell density cultures
06/07/12Human binding molecules having killing activity against staphylococci and uses thereof
04/05/12Recombinant viral-based malaria vaccines
03/29/12Host cell specific binding molecules capable of neutralizing viruses and uses thereof
12/22/11Settings for recombinant adenoviral-based vaccines
11/17/11Multivalent vaccines comprising recombinant viral vectors
11/03/11Human binding molecules having killing activity against enterococci and uses thereof
10/20/11Multivalent vaccines comprising recombinant viral vectors
09/22/11Purification of factor v
06/23/11Recombinant viral-based malaria vaccines
05/26/11Agonistic binding molecules to the human ox40 receptor
12/09/10Binding molecules capable of neutralizing rabies virus and uses thereof
12/09/10Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
12/09/10Packaging cells for recombinant adenovirus
11/25/10Binding molecules for treatment and detection of cancer
10/28/10Binding molecules capable of neutralizing rabies virus and uses thereof
09/02/10Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby
07/22/10Binding molecules for the treatment of myeloid cell malignancies
07/08/10Binding molecules against sars-coronavirus and uses thereof
Patent Packs
07/08/10Recombinant viral-based malaria vaccines
06/10/10Complementation of factor xi deficeincy by factor v mutants
03/11/10Purification of factor xi
02/18/10Novel assay for the separation and quantification of hemagglutinin antigens
02/11/10Serotype of adenovirus and uses thereof
01/21/10Settings for recombinant adenoviral-based vaccines
12/31/09Production of vaccines
10/22/09Recombinant production of mixtures of antibodies
10/08/09Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
09/24/09Production of vaccines
07/02/09Recombinant protein production in a human cell
05/21/09Optimization of west nile virus antibodies
05/14/09Virus purification using ultrafiltration
04/16/09Cell line for producing coronaviruses
01/21/10Settings for recombinant adenoviral-based vaccines
Patent Packs







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Crucell Holland B v in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Crucell Holland B v with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';